Ruth Strauss Foundation have grants up to £50,000 available for research into Non-Smoking #LungCancer; to improve understanding, diagnosis & quality of life 🫁 🗓️ Apply by 10 Jan 2026 #LCSM ruthstraussfoundation.com/grants-progr...

🌍 Today is World Lung Day - a platform to advocate for better lung health. It’s also the next step in our 2025 campaign 💟 & 10 new voices are here! Thank you to everyone who’s taken part - together we’re shifting assumptions about #LungCancer & helping more people get diagnosed earlier. #LCSM

🎉 Our official finalist blog feature is now live! All You Need Is Lungs is a finalist for Best Charity Campaign at the 2025 UK Social Media Awards. Our entry? 100% organic, 1st-person stories, created in partnership with our volunteers. #LCSM #LungCancer uksocialmediaawards.com/2025/09/10/a...

‘For decades, #lungcancer has been viewed as a disease of older men who smoked. Now, cases among young women are on the rise and doctors are baffled. Could air pollution be behind it?’ #LCSM www.theguardian.com/society/2025...

A cough that just wouldn’t go away was James’ first sign of lung cancer. “I’m a 45-year-old dad of 3 boys. I was diagnosed with stage 4 ALK+ #lungcancer in 2024 after a cough that got so bad I couldn’t hold a conversation.” #LCSM Read James story 👉 www.allyouneedislungs.org.uk/2025voices/j...

Alice was 39 when she learned she had stage 4 ROS1+ #lungcancer. Before that, she was told it was asthma, then pneumonia, & even spent 2 months in hospital. Lung cancer doesn’t discriminate - it can happen to anyone. #LCSM www.allyouneedislungs.org.uk/2025voices/a...

Sylvie’s back pain was dismissed as sciatica but it was actually a sign of #lungcancer. “I’m Sylvie, a 48 year old mum of 3 who adores travelling. In Nov 2023, I was diagnosed with stage 4 ALK+.” Sylvie is one of 10 voices in our 2025 campaign preview - showing anyone can get lung cancer. #LCSM

“I’m Eve, 44, French, & live in the North East with my husband & our 2 girls. 
I was diagnosed with stage 4 EGFR+ #lungcancer in Jan 2023 after a year-long cough & being sent home a couple of times.” Eve 💟 is one of the voices in our 2025 All You Need is Lungs campaign. tinyurl.com/ysvuavmc #LCSM

Our award-winning See Through the Symptoms campaign is back! Launched today for World #LungCancer Day, the campaign returns with a brand-new website - ready to support early diagnosis in primary care. See Through the Symptoms is part of All You Need Is Lungs. www.seethroughthesymptoms.uk #LCSM

Tina 💟 was one of our brilliant volunteers for 2024 & found it a really positive experience for her & her family. It’s your last chance to send your #lungcancer story & be guaranteed to be included in our 2025 campaign. Portal closes 31 July. www.allyouneedislungs.org.uk/volunteer-hub #LCSM

Wow - blown away doesn’t cover it!! All You Need Is Lungs is a finalist in the 2025 #UKSocialMediaAwards! 💟 A campaign with no media budget, no agency - just real voices from people living with non-smoking #lungcancer. Thank you 🙏 to all our incredible ‘voices’ for making this possible! #LCSM

Tina, a mum & grandma, refuses to let Stage 4 ALK+ #lungcancer stop her from planning for the future. Being diagnosed in 2021 was a huge shock, esp as a never-smoker. Symptoms included a persistent cough & ongoing chest/upper back pain. #LCSM www.allyouneedislungs.org.uk/volunteers-v...

What #ASCO25 results could shift clinical practice in the UK? 💡 From immunotherapy breakthroughs to precision diagnostics—get the key insights in just 1 hour! 🗓️ Mon 16 June | 🖥️ Free BTOG webinar www.btog.org/asco-update-... #LCSM #LungCancer #ThoracicOncology #BTOGASCO2025Webinar

📣 Our volunteer hub is now open! Share your story of living with mutation-driven #LungCancer 🫁 for this year’s Lung Cancer Awareness Month (November). We’re looking for real UK experiences to show: anyone can get lung cancer #AllYouNeedIsLungs. 👉 www.allyouneedislungs.org.uk/volunteer-hub

Gini & Deepa from our #AllYouNeedIsLungs team spoke at SELCA’s Early Diagnosis of Lung Cancer Community of Practice this week, highlighting our 2 campaigns: 💟 All You Need Is Lungs - for the public 💡 See Through the Symptoms - for HCPs Awareness is key to earlier #lungcancer diagnosis. #LCSM

🚴‍♀️ Mel, amazing member of our EGFR+ UK community, appeared on BBC Breakfast this morning alongside Sir Chris Hoy to talk about #TourDe4 & living with stage 4 #lungcancer. She shared her story, her strength, & why this ride matters. 📺 Watch here: youtu.be/HqGqmuL5Q7E #EGFRPositive #LCSM

Discover 26 powerful real-life stories from people living with #LungCancer - from first symptoms to challenging diagnoses to finding strength & hope. Showing the realities of lung cancer & the resilience of those affected. www.allyouneedislungs.org.uk/volunteers-v... #LSCM

Facial paralysis was a surprising red flag of #lungcancer for Jenny diagnosed with Stage 4 EGFR+. Since she's embraced a new perspective, finding joy in life's little moments. Jenny’s story: www.allyouneedislungs.org.uk/volunteers-v... We're now accepting submissions for our 2025 campaign! #LCSM

It’s time to challenge the stereotypes & raise awareness that anyone can get #lungcancer regardless of age or smoking status. #AllYouNeedIsLungs We’re looking for ‘voices’ for our 2025 campaign. Help us change the narrative. #LCSM Submit your story: www.allyouneedislungs.org.uk/volunteer-hub

EGFR Positive Lung Cancer UK - Being told you have lung cancer is life-changing @egfrpositiveuk.bsky.social oncodaily.com/blog/egfr-po... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer

We have 2 spaces in #LondonMarathon2026 🏃🏃‍♂️ run for us to help support people living with EGFR+ #lungcancer. 7,000 people in the UK are diagnosed with EGFR+ every year - no one should have to face this alone. #LCSM mailchi.mp/egfrpositive...

Great to see this important step for our EGFR mutant patients: FLAURA-2 approval by NICE. Interesting to note that the reimbursement (Blueteq form) allows a single cycle of chemo if clinically urgently indicated, but no access if PD on adjuvant osi. @btog.bsky.social @egfrpositiveuk.bsky.social

New pharmacy funding = more chances to spot #lungcancer early. allyouneedislungs.org.uk & seethroughthesymptoms.uk/ collab initiatives by ALK+ UK, EGFR+ UK & the Ruth Strauss Foundation have resources to help pharmacy teams raise the red flag 🚩 when symptoms don’t feel right. #LCSM

Looking forward @lungcancereurope.bsky.social’s AGM in Berlin next week. It’s a tremendous opportunity to work cohesively across Europe bringing synergies in patient advocacy. We’re particularly interested to take part in the masterclass on AI for #lungcancer patient advocacy. #LCSM

🧐 Are you a 🇬🇧 Healthcare Professional treating lung cancer? 🤔 Do you want to learn how clinical research runs, whilst advancing your career? 💥 Be an Associate PI of a trial! 🥳 eVOLVE-Lung02 (I am 🇬🇧 CI) accepted into NIHR Associate PI programme Details here 👇 www.nihr.ac.uk/career-devel...

Tonight on ITV, ‘Cancer Under 50’ examines the worrying increase in cancer diagnoses among people under 50. The programme features Sylvie from London, who was diagnosed with stage 4 ALK+ #lungcancer at 46. Sylvie, who has never smoked, experienced symptoms that were initially overlooked. #LCSM

Natasha Loveridge steps down as Marketing Trustee of EGFR+ UK after 18 impactful months. Known for her relentless energy & warmth, Natasha has significantly raised awareness about #lungcancer in non-smokers. While stepping back we’re grateful she remains a key part of our team. 🙏 Natasha! #LCSM

New insights: Targeting the agrin-EGFR interaction could lead to new treatment options for advanced EGFR+ #lungcancer. Learn more about this study: advanced.onlinelibrary.wiley.com/doi/10.1002/... #EGFR #LungCancerResearch #LCSM

New data from the LAURA trial shared at #ELCC25 today shows promising results for Stage 3 unresectable EGFR+ #lungcancer. Giving osimertinib after chemoradiation meant people went much longer before needing further treatment — over 40 months, compared to just 9 months without it. #LCSM

Just presented at #ELCC25: MARIPOSA confirms a survival benefit—amivantamab + lazertinib shows a 25% OS advantage (60% alive at 3 years) vs osimertinib in advanced EGFR+ #lungcancer. A breakthrough—but people in the UK are still waiting for access. #LCSM

Yesterday EGFR+ UK trustees met for a full strategy day. We worked through priorities for the year ahead, all with one goal in mind: improving outcomes for people with EGFR+ #lungcancer. Thanks to Angela, Gini, Soumitra, Natasha & Liz for their energy, focus & commitment 💜. #LCSM

It’s time to challenge the stereotypes—& raise awareness that anyone can get #lungcancer regardless of age or smoking status. #AllYouNeedIsLungs We’re looking for ‘voices’ for our 2025 campaign. Help us change the narrative. #LCSM Show your interest: www.allyouneedislungs.org.uk/2025-volunte...

MARIPOSA shows a 25% OS benefit for amivantamab + lazertinib vs osimertinib in newly diagnosed EGFR+ advanced #lungcancer. A big moment—but not simple. Side effects, IV treatment & QoL all matter. & right now, this option isn’t available for our UK EGFR+ community. Full results at #ELCC25 #LCSM

🔥 @natmedicine.bsky.social 🆙 ✅Molecular residual disease analysis of adj osimertinib in resected EGFR-mutated stage IB–IIIA NSCLC 🎯MRD preceded imaging DFS by a median of 4.7 🩸RaDaR MRD analysis 👥 Dr. Roy Herbst @drtomjohn.bsky.social #LCSM @oncoalert.bsky.social www.nature.com/articles/s41...

EGFR Positive Lung Cancer UK - One story can change medical practice @egfrpositiveuk.bsky.social oncodaily.com/blog/egfr-po... #Cancer #CancerResearch #LungCancer #EGFR #LCSM #Medicine #Health #Oncology #OncoDaily

New review on ADCs in #lungcancer “These are now being explored in other oncogene-driven subsets, including ALK…” Still early days—but could help when TKIs stop working. Worth watching #LCSM www.cancertreatmentreviews.com/article/S030...

The training was for staff in roles across the surgery, along with their own GPs and others who join them as a training centre. I’m very grateful to BCHC for taking this on, and hope it can inspire other surgeries to remind staff that #AllYouNeedIsLungs to get #LungCancer.

After Christine passed away in Oct 2024, her husband Sean met with her GP surgery to discuss her delayed EGFR+ #lungcancer diagnosis. Now, Banbury Cross Health Centre has made lung cancer in non-smokers part of their GP training. 💬 Patient advocacy changes conversations & outcomes. #LCSM

NEW Nature Medicine study: Molecular residual disease (MRD) in EGFR+ #lungcancer could help predict recurrence & guide future treatment strategies. #LCSM www.nature.com/articles/s41...

Amanda Procter from Maggie’s Yorkshire joined our EGFR+ UK #lungcancer community to discuss how @maggiescentres.bsky.social offer emotional, psychological, & practical support alongside NHS care. Watch the full conversation & more ‘Meet the Expert’ sessions: www.egfrpositive.org.uk/videos 💜 #LCSM

"New at JCAT-radiology 'Comprehensive Potential of Artificial Intelligence for Predicting PD-L1 Expression and EGFR Mutations in Lung Cancer: A Systematic Review and Meta-Analysis' Jan/Feb 25 dlvr.it/THclWZ Au: Linyong Wu et al. #AI #CT #LungCancer

Dr. Karen Yun presenting: How Do You Read a Molecular Testing Report? What are Driver Alterations in Lung Cancer? #TargetedTherapiesInLungCancer #LungCancer #ALK #ROS1 #RET #NTRK #EGFR #BRAF #MET #HER2 #KRAS

Q&A session with Drs. @lungoncdoc, @MMarmarelis, @LudaBazhenovaMD, and @IyengarPuneeth Is it better to continue on the same therapy as long as possible? #TargetedTherapiesInLungCancer #LungCancer

Today is #NationalCancerCNSDay, and we want to say a massive thank you💜 For those of us with EGFR+ #lungcancer, CNSs are a lifeline. They listen, reassure, and fight for us when it matters most. We quite simply couldn’t do this without you! #LCSM

New research published in the Journal of Clinical Oncology shows that Datroway (datopotamab deruxtecan) is making significant strides in treating advanced non-small cell lung cancer with actionable genomic alterations, particularly in the EGFR and ALK subtypes. #lungcancer

📊 40% of #lungcancer patients say they didn’t get enough details about their diagnosis.* 📊 22% of UK EGFR+ patients don’t know their mutation type—even though it affects treatment.** Patients can’t make informed choices without the right info. #LCSM * LuCE 9th Report ** EGFR+ UK member survey

Adjuvant Osimertinib in EGFR-Mutated #lungcancer: The Survival Curves Reveal the Next Set of Questions on How to Optimise Benefits #LCSM dailynews.ascopubs.org/do/adjuvant-...

Health equality doesn’t just happen—it takes people speaking up, pushing for better & refusing to accept less. Today, on #InternationalWomenDay, we’re recognising the women driving change in EGFR+ #lungcancer & beyond. Your determination, resilience & advocacy make a difference every day 🙏. #LCSM

Grateful to have these brilliant oncologists in our corner! They help us push for better EGFR+ #lungcancer care - keep up with research, drive access to treatment, & support our community. Dr Riyaz Shah, Dr Shobhit Baijal, Dr Alex Georgiou, Dr Yvonne Summers (from top left). Thank you! 🙏 #LCSM

Debra Montague on ensuring the patient voice is not lost. The most important person in the room after all! We haven’t lost the patient voice but we all need to be better at listening! #BTOG25